The application of virus-like particles as vaccines and biological vehicles

文献类型: 外文期刊

第一作者: Yan, Dan

作者: Yan, Dan;Wei, Yan-Quan;Guo, Hui-Chen;Sun, Shi-Qi;Yan, Dan;Wei, Yan-Quan;Guo, Hui-Chen;Sun, Shi-Qi

作者机构:

关键词: Virus-like particles;VLPs;Vaccine;Drug delivery;Diagnostic technology

期刊名称:APPLIED MICROBIOLOGY AND BIOTECHNOLOGY ( 影响因子:4.813; 五年影响因子:4.697 )

ISSN:

年卷期:

页码:

收录情况: SCI

摘要: Virus-like particles (VLPs) can be spontaneously self-assembled by viral structural proteins under appropriate conditions in vitro while excluding the genetic material and potential replication probability. In addition, VLPs possess several features including can be rapidly produced in large quantities through existing expression systems, highly resembling native viruses in terms of conformation and appearance, and displaying repeated cluster of epitopes. Their capsids can be modified via genetic insertion or chemical conjugation which facilitating the multivalent display of a homologous or heterogeneous epitope antigen. Therefore, VLPs are considered as a safe and effective candidate of prophylactic and therapeutic vaccines. VLPs, with a diameter of approximately 20 to 150 nm, also have the characteristics of nanometer materials, such as large surface area, surface-accessible amino acids with reactive moieties (e.g., lysine and glutamic acid residues), inerratic spatial structure, and good biocompatibility. Therefore, assembled VLPs have great potential as a delivery system for specifically carrying a variety of materials. This review summarized recent researches on VLP development as vaccines and biological vehicles, which demonstrated the advantages and potential of VLPs in disease control and prevention and diagnosis. Then, the prospect of VLP biology application in the future is discussed as well.

分类号: Q939.9`Q81

  • 相关文献

[1]Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques. Gai Weiwei,Gai Weiwei,Zhao Yongkun,Wang Qi,Wang Hualei,Xie Ying,Wang Haijun,Cao Zengguo,Feng Na,Chi Hang,Wang Tiecheng,Gao Yuwei,Yang Songtao,Xia Xianzhu,Zheng Xuexing,Wang Chong,Wang Qi,Wong Gary,Shan Junjie.

[2]Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses. Wu, Peipei,Lu, Jihu,Zhang, Xuehua,Mei, Mei,Feng, Lei,Hou, Jibo,Tang, Yinghua,Wu, Peipei,Lu, Jihu,Zhang, Xuehua,Mei, Mei,Feng, Lei,Hou, Jibo,Tang, Yinghua,Wu, Peipei,Lu, Jihu,Zhang, Xuehua,Mei, Mei,Feng, Lei,Peng, Daxin,Hou, Jibo,Liu, Xiufan,Tang, Yinghua,Peng, Daxin,Liu, Xiufan,Kang, Sang-Moo. 2017

[3]Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken. Li, Xin,Ju, Houbin,Liu, Jian,Yang, Dequan,Qi, Xinyong,Yang, Xianchao,Ge, Feifei,Zhou, Jinping,Qiu, Yafeng,Zheng, Jie. 2017

[4]Virus-like particles in picornavirus vaccine development. Dong, Hu,Guo, Hui-Chen,Sun, Shi-Qi.

[5]H5N1 influenza virus-like particle vaccine protects mice from heterologous virus challenge better than whole inactivated virus. Ren, Zhiguang,Qin, Chuan,Xia, Xianzhu,Ren, Zhiguang,Qin, Chuan,Xia, Xianzhu,Ren, Zhiguang,Ji, Xianliang,Meng, Lingnan,Wei, Yurong,Wang, Tiecheng,Feng, Na,Zheng, Xuexing,Wang, Hualei,Li, Nan,Gao, Xiaolong,Zhao, Yongkun,Yang, Songtao,Gao, Yuwei,Xia, Xianzhu,Ji, Xianliang,Meng, Lingnan,Wei, Yurong,Jin, Hongli,Gao, Yuwei,Xia, Xianzhu,Gao, Yuwei,Xia, Xianzhu.

[6]A multivalent killed whole-cell vaccine induces effective protection against Edwardsiella tarda and Vibrio anguillarum. Sun, Yun,Sun, Li,Liu, Chun-sheng,Sun, Yun.

[7]Comparative study of the immune effect of an Edwardsiella tarda antigen in two forms: Subunit vaccine vs DNA vaccine. Sun, Yun,Sun, Li,Sun, Yun,Liu, Chun-Sheng.

[8]Selective synthesis of Fe3O4AuxAgy nanomaterials and their potential applications in catalysis and nanomedicine. Fodjo, Essy Kouadio,Serge, Brou Yapi,Trokourey, Albert,Gabriel, Koffi Mouroufie,Li, Dan,Kong, Cong. 2017

[9]Foot-and-mouth disease virus-like particles as integrin-based drug delivery system achieve targeting anti-tumor efficacy. Yan, Dan,Teng, Zhidong,Sun, Shiqi,Dong, Hu,Gao, Yuan,Wei, Yanquan,Liu, Xiangtao,Yin, Hong,Guo, Huichen,Yan, Dan,Teng, Zhidong,Sun, Shiqi,Dong, Hu,Gao, Yuan,Wei, Yanquan,Liu, Xiangtao,Yin, Hong,Guo, Huichen,Jiang, Shan,Qin, Wenwu. 2017

[10]Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon. Li, Puwang,Yang, Ziming,Peng, Zheng,Li, Sidong,Kong, Lingxue,Wang, Qinghuang,Wang, Yichao,Kong, Lingxue,Wang, Qinghuang. 2015

[11]Cutting Edge Protein and Carbohydrate-Based Materials for Anticancer Drug Delivery. Ahmad, Rasheed,Deng, Yan,Hussain, Mubashir,He, Nongyue,Ahmad, Rasheed,Sun, Yueming,Shah, Muhammad Ali Abdullah,Singh, Ravina,Elingarami, Sauli,Deng, Yan,He, Nongyue. 2018

[12]Manufacturing Techniques and Surface Engineering of Polymer Based Nanoparticles for Targeted Drug Delivery to Cancer. Wang, Yichao,Wang, Yichao,Li, Puwang,Thao Truong-Dinh Tran,Zhang, Juan,Kong, Lingxue,Li, Puwang,Thao Truong-Dinh Tran. 2016

[13]Nanogels fabricated by lysozyme and sodium carboxymethyl cellulose for 5-fluorouracil controlled release. Zhu, Kunkun,Ye, Ting,Liu, Jinjin,Xu, Shasha,Lei, Jieqiong,Deng, Hongbing,Li, Bin,Zhu, Kunkun,Ye, Ting,Liu, Jinjin,Xu, Shasha,Lei, Jieqiong,Deng, Hongbing,Li, Bin,Zhu, Kunkun,Peng, Zheng.

[14]Nanostructured calcium phosphate carriers for deliver of poor water-soluble drug silybin. Chen, Lei,Zhu, Hualing,Yang, Song,Zhou, Beibei,You, Fenghui,Yan, Xiaoming.

[15]Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2. Pan, Qunxing,He, Kongwang,Pan, Qunxing,Huang, Kehe. 2008

[16]Porcine epidemic diarrhea virus virus-like particles produced in insect cells induce specific immune responses in mice. Wang, Cuiling,Wang, Cuiling,Yan, Feihu,Zheng, Xuexing,Wang, Hualei,Jin, Hongli,Wang, Chong,Zhao, Yongkun,Feng, Na,Wang, Tiecheng,Gao, Yuwei,Yang, Songtao,Xia, Xianzhu,Zheng, Xuexing,Jin, Hongli,Wang, Chong,Zheng, Xuexing,Wang, Hualei,Zhao, Yongkun,Feng, Na,Wang, Tiecheng,Gao, Yuwei,Yang, Songtao,Xia, Xianzhu.

[17]Development of a VLP-based vaccine in silkworm pupae against rabbit hemorrhagic disease virus. Zheng, Xuexing,Zheng, Xuexing,Wang, Shukun,Zhang, Weijiao,Liu, Xingjian,Yi, Yongzhu,Yang, Songtao,Xia, Xianzhu,Li, Yinv,Zhang, Zhifang,Zhang, Weijiao,Yang, Songtao,Xia, Xianzhu.

[18]M protein is sufficient for assembly and release of Peste des petits ruminants virus-like particles. Wang, Qiuxia,Ou, Changbo,Liu, Xingyou,Yu, Yan,Jiang, Jinqing,Ma, Jinyou,Hu, Jianhe,Wang, Qiuxia,Dou, Yongxi,Chen, Lei,Meng, Xuelian,Zhang, Zhidong,Cai, Xuepeng,Cai, Xuepeng.

[19]Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice. Wang, Chong,Gai, Weiwei,Wang, Hualei,Jin, Hongli,Feng, Na,Zhao, Yongkun,Zhang, Weijiao,Li, Nan,Zhao, Guoxing,Gao, Yuwei,Yang, Songtao,Xia, Xianzhu,Wang, Chong,Zheng, Xuexing,Gai, Weiwei,Zhang, Weijiao,Wong, Gary,Yan, Jinghua,Wang, Hualei,Feng, Na,Zhao, Yongkun,Gao, Yuwei,Yang, Songtao,Xia, Xianzhu,Hu, Guixue.

[20]Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs. Liu, Xinsheng,Fang, Yuzhen,Zhou, Peng,Lu, Yanzhen,Zhang, Qiaoling,Xiao, Shuai,Dong, Zhaoliang,Pan, Li,Lv, Jianliang,Zhang, Zhongwang,Zhang, Yongguang,Wang, Yonglu,Liu, Xinsheng,Fang, Yuzhen,Zhou, Peng,Lu, Yanzhen,Zhang, Qiaoling,Xiao, Shuai,Dong, Zhaoliang,Pan, Li,Lv, Jianliang,Zhang, Zhongwang,Zhang, Yongguang,Wang, Yonglu,Lu, Yanzhen,Xiao, Shuai.

作者其他论文 更多>>